Interventional cardiology in a whole new light

Open menu

News & Events

OPSENS SOLUTIONS FURTHER EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH USPTO GRANT

11 June 2019

Quebec City, Quebec, June 11, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that its wholly-owned subsidiary Opsens Solutions Inc. (“Opsens Solutions”), has been granted a patent for an innovative optical-based pressure sensor from the United States Patent and Trademark Office (“USPTO”). Patent no. 10,082,437 entitled “Optical Pressure Sensor with Reduced…

Read more

Visit Opsens Solutions at the SIAE Le Bourget 2019

7 June 2019

Opsens Solutions will be exhibiting at the SIAE Le Bourget 2019, the International Paris Airshow, in France from June 17-23. Please come to visit us at booth C80, Hall 3

OPSENS TO PRESENT AT THE LD MICRO INVITATIONAL

22 May 2019

Quebec City, Quebec, May 22, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a company focusing mainly on physiological measurements such as Fractional Flow Reserve (“FFR”) and Diastolic Pressure Ratio (“dPR”) in interventional cardiology, will present at the LD Micro 9th Invitational investor conference on Tuesday, June 4, 2019 at 8:40 am PST. Louis Laflamme, Opsens’…

Read more

Visit Opsens at C3 2019

10 May 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at the C3 2019 Conference by attending Opsens’ complimentary lunch  and educational symposium.  The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with confidence. Opsens second…

Read more

Visit Opsens at EuroPCR 2019

10 May 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at EuroPCR 2019 by attending Opsens’ complimentary Case-In-Point session or visit Opsens at the exhibition: Booth #64, level 2. The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with…

Read more

OPSENS SIGNS LANDMARK SUPPLIER AGREEMENT – EXPANDS OPTICAL SENSING TECHNOLOGY IMPACT WITHIN CARDIOLOGY SEGMENT

30 April 2019

Quebec City, Quebec, April 30, 2019 – Opsens inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is pleased to announce it has entered into a supply agreement as part of its long-term collaboration with Abiomed, Inc. (“Abiomed”) for the Impella CP® heart pump. Abiomed has awarded Opsens a five-year agreement to supply a critical component for…

Read more

Visit Opsens at SCAI 2019

22 April 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at SCAI 2019 (Society for Cardiovascular Angiography & Interventions) by attending Opsens’ complimentary lunch  and educational symposium.  Register Now! The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat…

Read more

OPSENS – Q2 2019 REVENUES REACH $7.9 M, A 46% INCREASE

11 April 2019

Quebec City, Quebec, April 11, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the second quarter of 2019. Highlights Consolidated revenues totaled $7.9 M in the second quarter of 2019 compared with $5.4 M in the corresponding period in 2018, an increase of $2.5 M or 46%; Fractional…

Read more

Visit Opsens at St. Francis Optimizing PCI (OPCI) 2019

5 March 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at the St. Francis Optimizing PCI (OPCI): Intravascular Imaging & Coronary Physiology Conference by attending Opsens’ complimentary hands-on workshop.  Space is limited, reserve your seat now!  Hands-On Workshop “Right Technique, Right Device for Physiologic Assessments” Saturday, March 9, 2019 Program Times:…

Read more

OPSENS APPOINTS ALAN MILINAZZO AS EXECUTIVE CHAIRMAN OF THE BOARD OF DIRECTORS

4 March 2019

Quebec City, Quebec, March 4, 2019 – Opsens Inc. (“Opsens”) (TSX:OPS) (OTCQX:OPSSF) is pleased to announce the appointment of Mr. Alan Milinazzo as Executive Chairman of the Board of Directors. “We are delighted to see Alan, a renowned leader in the medical device industry, join us. Alan has had extensive success in building high-performance commercial…

Read more